Peptide
Dihexa
Dihexa is an angiotensin IV–derived research compound studied in preclinical neuroscience models involving HGF/c-Met signalling, synaptogenesis, neuronal plasticity and memory-associated pathways.
For research purposes only. Not for human consumption.
Research Use Only — Not For Human Consumption
Product Description
Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is a synthetic research compound derived from angiotensin IV-related peptide chemistry. It was developed for experimental investigation of signalling pathways associated with neuronal growth, synaptic formation and cognitive biology.
Preclinical studies indicate that Dihexa interacts with hepatocyte growth factor (HGF) and can enhance HGF-dependent activation of its receptor, c-Met. The HGF/c-Met system is involved in a range of cellular processes including growth, differentiation, migration and neuronal development.
Experimental studies using neuronal cultures have investigated Dihexa in relation to dendritic spine formation and synaptogenesis. In these models, its effects were reduced when HGF/c-Met signalling was inhibited, supporting this pathway as an important focus of Dihexa research. Animal studies have additionally explored the compound in experimental models of learning and memory.
Dihexa may therefore be of interest to researchers studying:
- HGF/c-Met receptor signalling
- Synaptogenesis
- Dendritic spine formation
- Neuronal growth and plasticity
- Neurotrophic signalling pathways
- Memory and learning models
- Angiotensin IV-derived compounds
- Experimental neuroscience
The published evidence for Dihexa remains preclinical, with research primarily involving cultured cells and animal models. These findings should not be interpreted as demonstrating safety, efficacy or therapeutic effects in humans.
For laboratory and research purposes only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.